BioVinc presentation in 2024 ARI Orthopaedics Conference – Orthopaedic Infection

BioVinc scientists and collaborators presented data at the 2024 ARI Orthopaedics Conference – Orthopaedic Infection which will be held on June 24 – 26, 2024.  Ren, Y.; Xue, T.; Lekkala, S.; Tay, A.; Wang H.; Ebetino, F.H.; Neighbors, J.; Sun, S.; Schwarz, E.M.; Xie, C. Osseointegration of Hydroxy Bisphosphonate-Conjugated Sitafloxacin (HBCS) during Skeletal Growth and…

nih-funding-support_reduced-size-1024x683

BioVinc Secures Multi-Million Dollar SBIR Fast-Track Grant from NIH/NIAID to Advance Treatment for Infected Fractures

BioVinc is thrilled to announce it has been awarded a prestigious multi-million dollar SBIR Fast-Track Phase I/II grant from the National Institutes of Health (NIH/NIAID). This funding will accelerate our research and development of cutting-edge treatments targeting infected fractures, a critical unmet medical need. Patients suffering from open fractures face an alarmingly high risk of…

BioVinc presentation in 2022 ORS meeting

BioVinc scientists and collaborators will present data at the ORS 2022 Annual Meeting. The meeting will be held on February 4 – 8, 2022. Xie, C.; de Bentley, K.L.; Xue, T.; Ren, Y.; Saito, M.; Ebetino, F.H.; Sun, S.; Schwarz, E.M. Development of bisphosphonate-conjugated antibiotics to target Staphylococcus aureus biofilm within the osteocyte lacuno-canalicular network…

BioVinc presentation in 2021 ICPC meeting

BioVinc scientists and collaborators will present data at the 2021 23rd International Conference on Phosphorus Chemistry (ICPC) which will be held on July 5 – 9, 2021 as a virtual meeting. Ebetino, F.H.; Sun, S.; Cherian, P.; Srinivasan, V.; Hu, E.; Neighbors, J.D.; Roshandal, S.; McKenna, C. E.; Xie, C.; Schwarz, E.M.; Sedghizadeh, P.; Xing,…